Bisphosphonates reduce skeletal morbidity in cancer patients
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=188361Documentos Relacionados
- Bisphosphonates and skeletal morbidity in patients with metastatic cancer
- Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer
- Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer
- Do self-management plans reduce morbidity in patients with asthma?
- Recent developments in bisphosphonates for patients with metastatic breast cancer